Vamifeport - CAS 2095668-10-1

Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.

Ferroptosis, Ferroportin

Apoptosis, Membrane transporter/Ion channel

2095657

0.9991

C21H21FN6O2

408.43

Fc1cccnc1CNC(=O)c1coc(CCNCCc2nc3ccccc3[nH]2)n1

-20°C

Ice Packs

Small Compound